ESTRO Brachytherapy for Prostate Cancer 2018

First page Table of contents Previous page 800 Next page Last page

N=130 70% low risk

50Gy + 2x15Gy peripheral HDR Targetted focal boost to 60Gy

2 relapses

GU tox: G2: 11/130 G3: 2/130 GI tox: G2: 2/130

Made with FlippingBook - Online catalogs